Cargando…

Novel Pharmacological Interventions to Maintain Sinus Rhythm after DC Cardioversion

Despite the availability of potentially curative interventions for atrial fibrillation, there remains an important role for conventional anti-arrhythmic therapy and anti-coagulation combined with direct current cardioversion. Unfortunately, the latter approach is disturbed by high recurrence rates o...

Descripción completa

Detalles Bibliográficos
Autores principales: Thomas, D. E., Yousef, Z., Anderson, R. A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scholarly Research Network 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3262493/
https://www.ncbi.nlm.nih.gov/pubmed/22347630
http://dx.doi.org/10.5402/2011/176834
_version_ 1782221727612272640
author Thomas, D. E.
Yousef, Z.
Anderson, R. A.
author_facet Thomas, D. E.
Yousef, Z.
Anderson, R. A.
author_sort Thomas, D. E.
collection PubMed
description Despite the availability of potentially curative interventions for atrial fibrillation, there remains an important role for conventional anti-arrhythmic therapy and anti-coagulation combined with direct current cardioversion. Unfortunately, the latter approach is disturbed by high recurrence rates of atrial fibrillation. In recent years, several adjunctive therapies have emerged which may facilitate the maintenance of sinus rhythm. These novel therapies and their potential mechanisms of action are reviewed in this article.
format Online
Article
Text
id pubmed-3262493
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher International Scholarly Research Network
record_format MEDLINE/PubMed
spelling pubmed-32624932012-02-16 Novel Pharmacological Interventions to Maintain Sinus Rhythm after DC Cardioversion Thomas, D. E. Yousef, Z. Anderson, R. A. ISRN Cardiol Review Article Despite the availability of potentially curative interventions for atrial fibrillation, there remains an important role for conventional anti-arrhythmic therapy and anti-coagulation combined with direct current cardioversion. Unfortunately, the latter approach is disturbed by high recurrence rates of atrial fibrillation. In recent years, several adjunctive therapies have emerged which may facilitate the maintenance of sinus rhythm. These novel therapies and their potential mechanisms of action are reviewed in this article. International Scholarly Research Network 2011 2011-07-12 /pmc/articles/PMC3262493/ /pubmed/22347630 http://dx.doi.org/10.5402/2011/176834 Text en Copyright © 2011 D. E. Thomas et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Thomas, D. E.
Yousef, Z.
Anderson, R. A.
Novel Pharmacological Interventions to Maintain Sinus Rhythm after DC Cardioversion
title Novel Pharmacological Interventions to Maintain Sinus Rhythm after DC Cardioversion
title_full Novel Pharmacological Interventions to Maintain Sinus Rhythm after DC Cardioversion
title_fullStr Novel Pharmacological Interventions to Maintain Sinus Rhythm after DC Cardioversion
title_full_unstemmed Novel Pharmacological Interventions to Maintain Sinus Rhythm after DC Cardioversion
title_short Novel Pharmacological Interventions to Maintain Sinus Rhythm after DC Cardioversion
title_sort novel pharmacological interventions to maintain sinus rhythm after dc cardioversion
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3262493/
https://www.ncbi.nlm.nih.gov/pubmed/22347630
http://dx.doi.org/10.5402/2011/176834
work_keys_str_mv AT thomasde novelpharmacologicalinterventionstomaintainsinusrhythmafterdccardioversion
AT yousefz novelpharmacologicalinterventionstomaintainsinusrhythmafterdccardioversion
AT andersonra novelpharmacologicalinterventionstomaintainsinusrhythmafterdccardioversion